Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells

Blood

Volumn 96, Issue 1, 2000, Pages 176-181

  Van Der Schaft, Daisy W J ^a   Toebes, Elly A H ^b   Haseman, Judith R ^b   Mayo, Kevin H ^b   Griffioen, Arjan W ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; BASIC FIBROBLAST GROWTH FACTOR; CASPASE INHIBITOR; COLLAGEN GEL; DRUG VEHICLE; ENDOTOXIN; HEPARIN; THROMBOCYTE FACTOR 4; TRYPAN BLUE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0034234652     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.176.013k32_176_181     Document Type: Article

References (31)

1. Elsbach P, Weiss J. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr Opin Immunol. 1993;5:103-107.
2. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978;253:2664-2672.
3. Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun. 1984;45:29-35.
4. Hovde CJ, Gray BH. Characterization of a protein from normal human polymorphonuclear leukocytes with bactericidal activity against Pseudomonas aeruginosa. Infect Immun. 1986;54:142-148.
5. Wasiluk KR, Skubitz KM, Gray BH. Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa. Infect Immun. 1991; 59:4193-4200.
6. Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/ permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol. 1992; 148:532-537.
7. Heumann D, Gallay P, Betz-Corradin S, Barras C, Baumgartner JD, Glauser MP. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. J Infect Dis. 1993;167:1351-1357.
8. Little RG, Kelner DN, Lim E, Burke DJ, Conlon PJ. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem. 1994;269:1865-1872.
9. Mire-Sluis AR, Thorpe R. Cytokines. San Diego, Academic Press; 1998.
10. Darveau RP, Blake J, Seachord CL, et al. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest. 1992;90:447-455.
11. Gupta SK, Hassel T, Singh JP. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci U S A. 1995;92:7799-7803.
12. Maione TE, Gray GS, Petro J, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 1990;247: 77-79.
13. Molema G, Griffioen AW. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply. Immunol Today. 1998;19:392-394.
14. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.
15. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem. 1980;105: 361-363.
16. Uknis ME, Wasiluk KR, Acton RD, et al. Design of a potent novel endotoxin antagonist. Surgery. 1997;122:380-385.
17. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996;315:21-24.
18. Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res. 1995;50:311-322.
19. Trochon V, Li H, Vasse M, et al. Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro. Angiogenesis. 1998;2:277-285.
20. Cip1/WAF1. Blood. 1999;93:25-33.
21. Barendsz-Janson AF, Griffioen AW, Muller AD, Van Dam-Mieras MCE, Hillen HFP. In vitro tumor angiogenesis assays: plasminogen lysine binding site 1 (LBS-1) inhibits in vitro tumor induced angiogenesis. J Vasc Res. 1998;35:109-114.
22. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma. Cell. 1994;79:315-328.
23. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
24. Gray BH, Haseman JR, Mayo KH. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides. Biochim Biophys Acta. 1995;1244:185-190.
25. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994;264:569-571.
26. Brooks PC, Montgomery AMP, Rosenfeld M, et al. Integrin alpha-v beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
27. Dentener MA, Francot GJ, Smit FT, et al. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA. J Infect Dis. 1995;171:739-743.
28. Weiss J, Kao L, Victor M, Elsbach P. Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes. J Clin Invest. 1985;76:206-212.
29. Wadzinski MG, Folkman J, Sasse J, Devey K, Ingber D, Klagsbrun M. Heparin-binding angiogenesis factors: detection by immunological methods. Clin Physiol Biochem. 1987;5:200-209.
30. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
31. Smith WB, Gamble JR, Clark Lewis I, Vadas MA. Chemotactic desensitization of neutrophils demonstrates interleukin-8 (IL-8)-dependent and IL-8-independent mechanisms of transmigration through cytokine-activated endothelium. Immunology. 1993;78:491-497.